Grant: Collaborative Health Research Projects
McGill University
$118,762.00
Novel multilayered synthetic structural bone graft materials which combine biocompatibility, biodegradability and high toughness
FY 2018-19
Summary
Due to the ageing world population, techniques to replace, restore, or regenerate bone have*become a major clinical need in the fields of orthopaedic, spinal, dental, cranial, and*maxillofacial surgery. For these patients that suffer from bone loss and bone defects, surgical*treatment remains a major challenge. Traditional bone grafting techniques have performance*limitations including donor site morbidity, viral transmission, immunologic incompatibility, long*rehabilitation time and structural failure. The need for new strategies for the treatment of bone*defects is therefore urgent. The ideal bone graft material must: (i) match the mechanical*properties of healthy bone; (ii) be biocompatible and promote healing and (iii) must degrade*over time to be replaced by healthy bone. To this day, there is no synthetic material that can*fulfill these three requirements simultaneously. In this project we will develop a new structural*bone graft made from calcium sulfate, collagen and gelatin. All components of this material*are fully biocompatible and FDA-approved for use as biomaterials. The mineral content*provides stiffness, while the weaker protein layers can deflect incoming cracks to generate*toughness. The implication is that this material can be used to fabricate load-carrying grafts,*as opposed to traditional calcium phosphates/sulfates which are too brittle. The structural*bone graft can be of varying sizes and dimensions. In-vivo performance will be evaluated with*an animal study. In addition, bone grafts with complex patient-specific shapes will be*developed using 3D printed polymeric templates. This new medical technology will have a*significant impact on restoring functionality and quality of life in patients requiring*reconstruction of structural bone defects secondary to trauma, failed arthroplasties, bone*tumors, maxillofacial surgery or other bone diseases.
Program
Collaborative Health Research Projects
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
508413-2017
Name nom
Barthelat, Francois
Department département
Mechanical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2017
Award amount
118762
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2
Nb partie
3
Application title
Novel multilayered synthetic structural bone graft materials which combine biocompatibility, biodegradability and high toughness
Keyword
NSERC
Application summary
Due to the ageing world population, techniques to replace, restore, or regenerate bone have*become a major clinical need in the fields of orthopaedic, spinal, dental, cranial, and*maxillofacial surgery. For these patients that suffer from bone loss and bone defects, surgical*treatment remains a major challenge. Traditional bone grafting techniques have performance*limitations including donor site morbidity, viral transmission, immunologic incompatibility, long*rehabilitation time and structural failure. The need for new strategies for the treatment of bone*defects is therefore urgent. The ideal bone graft material must: (i) match the mechanical*properties of healthy bone; (ii) be biocompatible and promote healing and (iii) must degrade*over time to be replaced by healthy bone. To this day, there is no synthetic material that can*fulfill these three requirements simultaneously. In this project we will develop a new structural*bone graft made from calcium sulfate, collagen and gelatin. All components of this material*are fully biocompatible and FDA-approved for use as biomaterials. The mineral content*provides stiffness, while the weaker protein layers can deflect incoming cracks to generate*toughness. The implication is that this material can be used to fabricate load-carrying grafts,*as opposed to traditional calcium phosphates/sulfates which are too brittle. The structural*bone graft can be of varying sizes and dimensions. In-vivo performance will be evaluated with*an animal study. In addition, bone grafts with complex patient-specific shapes will be*developed using 3D printed polymeric templates. This new medical technology will have a*significant impact on restoring functionality and quality of life in patients requiring*reconstruction of structural bone defects secondary to trauma, failed arthroplasties, bone*tumors, maxillofacial surgery or other bone diseases.